Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oncogene

Showing results (731-740 of 22,566) with videos related to

Pageof 2,257
Sort By:
Oncogene|June 14, 2020
The BLIMP1-EZH2 nexus in a non-Hodgkin lymphomaKimberley Jade Anderson, Árný Björg Ósvaldsdóttir, Birgit Atzinger, et al.
Oncogene|May 20, 2020
Correction: A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1DS Rayter, R Elliott, J Travers, et al.
Oncogene|August 5, 2022
FOXA1 inhibits hypoxia programs through transcriptional repression of HIF1AXiaohai Wang, Lourdes Brea, Xiaodong Lu, et al.
Oncogene|August 6, 2022
A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancerMalene Blond Ipsen, Ea Marie Givskov Sørensen, Emil Aagaard Thomsen, et al.
Oncogene|September 7, 2021
FOXK2 transcriptionally activating VEGFA induces apatinib resistance in anaplastic thyroid cancer through VEGFA/VEGFR1 pathwayHaoran Feng, Zhijian Jin, Juyong Liang, et al.
Oncogene|September 7, 2021
The role of reciprocal fusions in MLL-r acute leukemia: studying the chromosomal translocation t(4;11)Alexander Wilhelm, Rolf Marschalek
Oncogene|September 7, 2021
LGR6 activates the Wnt/β-catenin signaling pathway and forms a β-catenin/TCF7L2/LGR6 feedback loop in LGR6<sup>high</sup> cervical cancer stem cellsQian Feng, Shan Li, Hong-Mei Ma, et al.
Oncogene|August 23, 2025
KDM1A-driven RNF81 downregulation promotes gastric cancer progression via KLF4 destabilizationFeng Wang, Po Hao, Yongli Pu, et al.
Oncogene|May 12, 2015
Therapeutic potential of targeting IRES-dependent c-myc translation in multiple myeloma cells during ER stressY Shi, Y Yang, B Hoang, et al.
Oncogene|May 12, 2015
TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxisM-F Pang, A-M Georgoudaki, L Lambut, et al.
Pageof 2,257

Showing results (731-740 of 22,566) with videos related to

Sort By:
Pageof 2,257
Oncogene|June 14, 2020
The BLIMP1-EZH2 nexus in a non-Hodgkin lymphomaKimberley Jade Anderson, Árný Björg Ósvaldsdóttir, Birgit Atzinger, et al.
Oncogene|May 20, 2020
Correction: A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1DS Rayter, R Elliott, J Travers, et al.
Oncogene|August 5, 2022
FOXA1 inhibits hypoxia programs through transcriptional repression of HIF1AXiaohai Wang, Lourdes Brea, Xiaodong Lu, et al.
Oncogene|August 6, 2022
A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancerMalene Blond Ipsen, Ea Marie Givskov Sørensen, Emil Aagaard Thomsen, et al.
Oncogene|September 7, 2021
FOXK2 transcriptionally activating VEGFA induces apatinib resistance in anaplastic thyroid cancer through VEGFA/VEGFR1 pathwayHaoran Feng, Zhijian Jin, Juyong Liang, et al.
Oncogene|September 7, 2021
The role of reciprocal fusions in MLL-r acute leukemia: studying the chromosomal translocation t(4;11)Alexander Wilhelm, Rolf Marschalek
Oncogene|September 7, 2021
LGR6 activates the Wnt/β-catenin signaling pathway and forms a β-catenin/TCF7L2/LGR6 feedback loop in LGR6<sup>high</sup> cervical cancer stem cellsQian Feng, Shan Li, Hong-Mei Ma, et al.
Oncogene|August 23, 2025
KDM1A-driven RNF81 downregulation promotes gastric cancer progression via KLF4 destabilizationFeng Wang, Po Hao, Yongli Pu, et al.
Oncogene|May 12, 2015
Therapeutic potential of targeting IRES-dependent c-myc translation in multiple myeloma cells during ER stressY Shi, Y Yang, B Hoang, et al.
Oncogene|May 12, 2015
TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxisM-F Pang, A-M Georgoudaki, L Lambut, et al.
Pageof 2,257